Work

Success for gene therapy: render unto Caesar that which is Caesar's.

Year: 2004

Type: article

Abstract: Reports that two young children developed leukemia after being treated for immunodeficiency with their own retrovirally modified bone-marrow cells delivered a severe blow to confidence in gene therapy as a treatment. Two reports, published since the trial was initiated, now take away some of the mystery as to why these events happened and allay fears for the safety of gene therapy across all therapeutic applications.

Source: Genome biology

DOI: 10.1186/gb-2004-5-8-237

Authors: Jian Qiao, Rosa Diaz, Richard G Vile

Institution: Mayo Clinic

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $5,490